Department of Medicine, Weill Cornell Medical College of Cornell University, 1300 York Avenue, New York, New York 10065, USA.
Nat Commun. 2013;4:2490. doi: 10.1038/ncomms3490.
A common single-nucleotide polymorphism (SNP) in the human brain-derived neurotrophic factor (BDNF) gene results in a Val66Met substitution in the BDNF prodomain region. This SNP is associated with alterations in memory and with enhanced risk to develop depression and anxiety disorders in humans. Here we show that the isolated BDNF prodomain is detected in the hippocampus and that it can be secreted from neurons in an activity-dependent manner. Using nuclear magnetic resonance spectroscopy and circular dichroism, we find that the prodomain is intrinsically disordered, and the Val66Met substitution induces structural changes. Surprisingly, application of Met66 (but not Val66) BDNF prodomain induces acute growth cone retraction and a decrease in Rac activity in hippocampal neurons. Expression of p75(NTR) and differential engagement of the Met66 prodomain to the SorCS2 receptor are required for this effect. These results identify the Met66 prodomain as a new active ligand, which modulates neuronal morphology.
人类脑源性神经营养因子(BDNF)基因中的一个常见单核苷酸多态性(SNP)导致 BDNF 前体区域中的 Val66Met 取代。该 SNP 与记忆改变以及人类患抑郁和焦虑障碍的风险增加有关。在这里,我们表明,分离的 BDNF 前体在海马体中被检测到,并且可以以活性依赖的方式从神经元中分泌出来。使用核磁共振波谱和圆二色性,我们发现前体是固有无序的,并且 Val66Met 取代诱导结构变化。令人惊讶的是,Met66(而不是 Val66)BDNF 前体的应用诱导海马神经元中的急性生长锥回缩和 Rac 活性降低。p75(NTR)的表达和对 SorCS2 受体的 Met66 前体的差异结合对于这种效应是必需的。这些结果确定 Met66 前体为一种新的活性配体,其调节神经元形态。